Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

• From the American Academy of Pediatrics

Clinical Practice Guideline

1. Shawn L. Ralston, MD, FAAP, 
2. Allan S. Lieberthal, MD, FAAP,
3. H. Cody Meissner, MD, FAAP, 
4. Brian K. Alverson, MD, FAAP,
5. Jill E. Baley, MD, FAAP, 
6. Anne M. Gadomski, MD, MPH, FAAP,
7. David W. Johnson, MD, FAAP, 
8. Michael J. Light, MD, FAAP,
9. Nizar F. Maraqa, MD, FAAP, 
10. Eneida A. Mendonca, MD, PhD, FAAP, FACMI, 
11. Kieran J. Phelan, MD, MSc, 
12. Joseph J. Zorc, MD, MSCE, FAAP,
13. Danette Stanko-Lopp, MA, MPH, 
14. Mark A. Brown, MD, 
15. Ian Nathanson, MD, FAAP, 
16. Elizabeth Rosenblum, MD, 
17. Stephen Sayles III, MD, FACEP, and 
18. Sinsi Hernandez-Cancio, JD

ABSTRACT

This guideline is a revision of the clinical practice guideline, “Diagnosis and Management of Bronchiolitis,” published by the American Academy of Pediatrics in 2006. The guideline applies to children from 1 through 23 months of age. Other exclusions are noted. Each key action statement indicates level of evidence, benefit-harm relationship, and level of recommendation. Key action statements are as follows:

This Article

1. Published online October 27, 2014

   PEDIATRICS Vol. 134 No. 5 November 1, 2014 

   pp. e1474 -e1502 

   (doi: 10.1542/peds.2014-2742)

1. Full TextFree
2. Full Text (PDF)Free